Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
gptkb:tosidotinib
|
| gptkbp:chemicalClass |
small molecule
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
gptkb:Imara_Inc.
|
| https://www.w3.org/2000/01/rdf-schema#label |
IMR-687
|
| gptkbp:intendedUse |
treatment of beta-thalassemia
treatment of sickle cell disease |
| gptkbp:mechanismOfAction |
PDE9 inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:bfsParent |
gptkb:Imara_Inc.
|
| gptkbp:bfsLayer |
7
|